<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00478257</url>
  </required_header>
  <id_info>
    <org_study_id>CBCRP 11IB-0034</org_study_id>
    <nct_id>NCT00478257</nct_id>
  </id_info>
  <brief_title>Effect of Increased Light Exposure on Fatigue in Breast Cancer</brief_title>
  <official_title>Effect of Increased Light Exposure on Fatigue in Breast Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Diego</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>California Breast Cancer Research Program</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of California, San Diego</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients treated with chemotherapy complain of poor sleep, fatigue and depression. In
      addition, chemotherapy disrupts the body's internal &quot;biological clock&quot;, which may make sleep,
      fatigue and depression all worse. Women with breast cancer undergoing chemotherapy are not
      exposed to much bright light and this may also contribute to the disruption of their body
      clock, because bright light is necessary for a strong biological clock. One of the easiest
      ways to strengthen the biological clock is by increasing bright light exposure. The correct
      timing of the light exposure will help the women feel more alert during the day.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients treated with chemotherapy complain of poor sleep, fatigue and depression. Our
      preliminary research suggests that these symptoms may all be related, that chemotherapy
      disrupts circadian rhythms which may exacerbate the poor sleep and fatigue and that during
      chemotherapy, women are not exposed to much bright light which likely also contributes to the
      disruption of rhythms. One of the easiest circadian rhythms to measure is sleep/wake activity
      and the easiest way to synchronize this rhythm is with bright light treatment. It is well
      established that bright light exposure will make rhythms more robust, and the correct timing
      of the light exposure will have an alerting effect.

      We hypothesize that after bright light treatment compared to dim light treatment during three
      cycles of chemotherapy: fatigue (measured by the Multidimensional Fatigue Symptom Inventory),
      depression (measured by the Center of Epidemiological Studies-Depression scale), functional
      outcome scores (measured by the Functional Outcome of Sleep Questionnaire and by the
      Functional Assessment of Cancer Therapy-Breast), and sleep measures (measured by actigraphy,
      e.g., total sleep time, total wake time, bouts of sleep, napping) will all be improved. We
      also hypothesize that circadian rhythms (measured by actigraphy) will be more robust and more
      synchronized.

      The aims are to examine the effect of bright light treatment on subjective measures of
      fatigue, mood and functional outcome experienced during chemotherapy, to examine the effect
      of bright light treatment on the quality and quantity of sleep during chemotherapy, to
      examine the effect of bright light treatment on sleep/wake rhythms during chemotherapy. Women
      with breast cancer stages I-III scheduled to begin chemotherapy will be recruited. Wrist
      actigraphy data (for the measurement of sleep/wake activity) will be collected for three
      consecutive days and nights immediately preceding chemotherapy and questionnaire data
      (fatigue, mood, quality of life, functional outcome, sleep) will be collected during this
      same time period. Half the women will be randomized to receive bright light and the other
      half to dim red light as a control. Daily bright light or dim light treatment will be
      administered during cycles 2, 3 and 4 of chemotherapy and all measures (actigraphy and
      questionnaires) will be repeated during the first and last weeks of cycle 1 and cycle 4
      chemotherapy. If bright light can improve sleep rhythms and fatigue, then the quality of life
      of these women is likely to improve.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2005</start_date>
  <completion_date type="Actual">November 2009</completion_date>
  <primary_completion_date type="Actual">November 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Fatigue</measure>
    <time_frame>four cycles of chemotherapy</time_frame>
    <description>The Short Form of the Multidimensional Fatigue Symptom Inventory (MFSI-sf) was used to measure fatigue. The range of possible score for each subscale is 0 to 24, and the range for total score is −24 to 96, with a higher score indicating more severe fatigue, except for the Vigor subscale, where larger score indicates less fatigue.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">39</enrollment>
  <condition>Breast Cancer</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Bright white light, the intervention, was administered via a light box made by Litebook Inc for 30 minutes each morning during four cycles of chemotherapy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Dim red light, the intervention, was administered via a light box made by Litebook Inc for 30 minutes each morning during four cycles of chemotherapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>bright white light administered via a light box made by Litebook, Inc</intervention_name>
    <description>Bright white light</description>
    <arm_group_label>1</arm_group_label>
    <other_name>Litebook</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>light box ( Litebook)</intervention_name>
    <description>dim red light</description>
    <arm_group_label>2</arm_group_label>
    <other_name>Litebook</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  stage I-III breast cancer

          -  adjuvant or neoadjuvant anthracycline-based chemotherapy

        Exclusion Criteria:

          -  under age 18

          -  pregnancy

          -  metastatic or inoperable (including inflammatory) breast cancer

          -  confounding underlying medical illnesses

          -  history of mania

          -  history of other axis-I psychiatric disorder

          -  other physical or psychological impairments -
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sonia Ancoli-Israel, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, San Diego</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Moores UCSD Cancer Center</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92093</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Ancoli-Israel S, Rissling M, Neikrug A, Trofimenko V, Natarajan L, Parker BA, Lawton S, Desan P, Liu L. Light treatment prevents fatigue in women undergoing chemotherapy for breast cancer. Support Care Cancer. 2012 Jun;20(6):1211-9. doi: 10.1007/s00520-011-1203-z. Epub 2011 Jun 11.</citation>
    <PMID>21660669</PMID>
  </results_reference>
  <results_reference>
    <citation>Jeste N, Liu L, Rissling M, Trofimenko V, Natarajan L, Parker BA, Ancoli-Israel S. Prevention of quality-of-life deterioration with light therapy is associated with changes in fatigue in women with breast cancer undergoing chemotherapy. Qual Life Res. 2013 Aug;22(6):1239-44. doi: 10.1007/s11136-012-0243-2. Epub 2012 Aug 3.</citation>
    <PMID>22865153</PMID>
  </results_reference>
  <results_reference>
    <citation>Neikrug AB, Rissling M, Trofimenko V, Liu L, Natarajan L, Lawton S, Parker BA, Ancoli-Israel S. Bright light therapy protects women from circadian rhythm desynchronization during chemotherapy for breast cancer. Behav Sleep Med. 2012;10(3):202-16. doi: 10.1080/15402002.2011.634940.</citation>
    <PMID>22742438</PMID>
  </results_reference>
  <verification_date>May 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 22, 2007</study_first_submitted>
  <study_first_submitted_qc>May 22, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 24, 2007</study_first_posted>
  <results_first_submitted>June 18, 2012</results_first_submitted>
  <results_first_submitted_qc>May 10, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">June 16, 2016</results_first_posted>
  <last_update_submitted>May 10, 2016</last_update_submitted>
  <last_update_submitted_qc>May 10, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 16, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of California, San Diego</investigator_affiliation>
    <investigator_full_name>Sonia Ancoli-Israel</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>fatigue</keyword>
  <keyword>sleep</keyword>
  <keyword>quality of life</keyword>
  <keyword>light</keyword>
  <keyword>cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
    <mesh_term>Fatigue</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Effect of Bright Light</title>
          <description>Effect of bright light on fatigue in women with breast cancer</description>
        </group>
        <group group_id="P2">
          <title>Effect of Red Light</title>
          <description>effect of red light on fatigue in women with breast cancer</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="23"/>
                <participants group_id="P2" count="16"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
                <participants group_id="P2" count="13"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Effect of Bright Light</title>
          <description>Effect of bright light on fatigue in women with breast cancer</description>
        </group>
        <group group_id="B2">
          <title>Effect of Red Light</title>
          <description>effect of red light on fatigue in women with breast cancer</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="23"/>
            <count group_id="B2" value="16"/>
            <count group_id="B3" value="39"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="54.3" spread="9"/>
                    <measurement group_id="B2" value="53.5" spread="9"/>
                    <measurement group_id="B3" value="53.9" spread="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="23"/>
                    <measurement group_id="B2" value="16"/>
                    <measurement group_id="B3" value="39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="23"/>
                    <measurement group_id="B2" value="16"/>
                    <measurement group_id="B3" value="39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Fatigue</title>
        <description>The Short Form of the Multidimensional Fatigue Symptom Inventory (MFSI-sf) was used to measure fatigue. The range of possible score for each subscale is 0 to 24, and the range for total score is −24 to 96, with a higher score indicating more severe fatigue, except for the Vigor subscale, where larger score indicates less fatigue.</description>
        <time_frame>four cycles of chemotherapy</time_frame>
        <population>All participants that were randomized and began the protocol were included in analyses.</population>
        <group_list>
          <group group_id="O1">
            <title>Effect of Bright Light</title>
            <description>Effect of bright light on fatigue in women with breast cancer</description>
          </group>
          <group group_id="O2">
            <title>Effect of Red Light</title>
            <description>effect of red light on fatigue in women with breast cancer</description>
          </group>
        </group_list>
        <measure>
          <title>Fatigue</title>
          <description>The Short Form of the Multidimensional Fatigue Symptom Inventory (MFSI-sf) was used to measure fatigue. The range of possible score for each subscale is 0 to 24, and the range for total score is −24 to 96, with a higher score indicating more severe fatigue, except for the Vigor subscale, where larger score indicates less fatigue.</description>
          <population>All participants that were randomized and began the protocol were included in analyses.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
                <count group_id="O2" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.25" spread="5.5"/>
                    <measurement group_id="O2" value="21.6" spread="7.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Effect of Bright Light</title>
          <description>Effect of bright light on fatigue in women with breast cancer</description>
        </group>
        <group group_id="E2">
          <title>Effect of Red Light</title>
          <description>effect of red light on fatigue in women with breast cancer</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="16"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>4</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="16"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Small sample size; only partial compliance data; light only administered in morning; only tested effect in patients with breast cancer.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr. Sonia Ancoli-Israel</name_or_title>
      <organization>UCSD</organization>
      <phone>858 642-7710</phone>
      <email>sancoliisrael@ucsd.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

